Smi Drug Discovery Limited
11175710
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/12/2025
total exemption full
Next accounts due
30/09/2027
Confirmation statement
Last: 06/01/2026
Due 20/01/2027
Industry
Officers
Persons with Significant Control
Norcliffe Nominees Limited
First Floor, 12/14 Mason's Avenue, London, EC2V 5BT
Reg: 11879190 · Companies House · Company Limited By Shares
Notified 01/02/2022
Former PSCs
Mr Andrew James Thompson
Ceased 03/04/2025
Change History
Active
Private Limited Company
23 LONGMEADOW
CAMBRIDGE
CompanyRankvs 193+ SIC 72110 peers80
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£1.1M
Balance sheet strength
Cash
£669k
Cash in the bank
Net Current Assets
£989k
Working capital
Current Assets
£1.1M
Current Liabilities
£87k
Fixed Assets
£142k
Debtors
£407k
Director Loans(2020)
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 12.42 | +£317k |
| 2023 | 9.83 | -£772k |
| 2022 | 21.72 | +£1.6M |
| 2021 | 7.33 | — |
| 2021 | 0.04 | — |
| 2020 | 0.21 | — |
Derived from filed accounts. Not audited figures.